Dashboard
Manage Tickers

SLDBSolid Biosciences Inc.

Nasdaq solidbio.com


$ 9.51 $ -0.14 (-1.45 %)    

Monday, 26-Aug-2024 15:07:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 475.48 $ -4.45 (-0.93 %)
DIA $ 412.33 $ -0.52 (-0.13 %)
SPY $ 560.46 $ -2.73 (-0.48 %)
TLT $ 98.26 $ -0.39 (-0.4 %)
GLD $ 232.82 $ -0.66 (-0.28 %)
$ 9.56
$ 9.65
$ 9.50 x 100
-- x --
$ 9.15 - $ 9.65
$ 1.81 - $ 15.05
297,042
na
368.97M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-13-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 03-14-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-13-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-10-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-29-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-solid-biosciences-lowers-price-target-to-15
Barclays Maintains Overweight on Solid Bio...
08/14/2024 14:40:07

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and lowers the price target from $18 ...

hc-wainwright--co-reiterates-buy-on-solid-biosciences-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Soli...
08/14/2024 12:17:10

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $16 price target.

solid-biosciences-q2-eps-061-beats-067-estimate
Solid Biosciences Q2 EPS $(0.61) Beats $(0...
08/13/2024 20:56:13

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0...

jp-morgan-upgrades-solid-biosciences-to-overweight-raises-price-target-to-15
JP Morgan Upgrades Solid Biosciences to Ov...
07/15/2024 12:04:35

JP Morgan analyst Anupam Rama upgrades Solid Biosciences (NASDAQ:SLDB) from Neutral to Overweight and raises the price targe...

solid-biosciences-joins-russell-3000-index
Solid Biosciences Joins Russell 3000 Index
07/01/2024 12:10:48

this-planet-fitness-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Planet Fitness Analyst Turns Bullish;...
06/24/2024 12:09:18

leerink-partners-upgrades-solid-biosciences-to-outperform-maintains-price-target-to-12
Leerink Partners Upgrades Solid Bioscience...
06/24/2024 11:13:10

Leerink Partners analyst Joseph Schwartz upgrades Solid Biosciences (NASDAQ:SLDB) from Market Perform to Outperform and main...

piper-sandler-reiterates-overweight-on-solid-biosciences-maintains-20-price-target
Piper Sandler Reiterates Overweight on Sol...
06/21/2024 17:50:13

Piper Sandler analyst Biren Amin reiterates Solid Biosciences (NASDAQ:SLDB) with a Overweight and maintains $20 price target.

why-sarepta-therapeutics-shares-are-trading-higher-by-around-35-here-are-20-stocks-moving-premarket
Why Sarepta Therapeutics Shares Are Tradin...
06/21/2024 12:22:36

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/21/2024 12:08:00

jp-morgan-maintains-neutral-on-solid-biosciences-lowers-price-target-to-10
JP Morgan Maintains Neutral on Solid Biosc...
05/31/2024 17:18:45

JP Morgan analyst Anupam Rama maintains Solid Biosciences (NASDAQ:SLDB) with a Neutral and lowers the price target from $12 ...

hc-wainwright--co-reiterates-buy-on-solid-biosciences-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Soli...
05/20/2024 11:27:01

HC Wainwright & Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:SLDB) with a Buy and maintains $16 price target.

barclays-maintains-overweight-on-solid-biosciences-lowers-price-target-to-18
Barclays Maintains Overweight on Solid Bio...
05/16/2024 14:46:43

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and lowers the price target from $21 ...

solid-biosciences-q1-eps-064-inline
Solid Biosciences Q1 EPS $(0.64), Inline
05/15/2024 12:01:29

Solid Biosciences (NASDAQ:SLDB) reported quarterly losses of $(0.64) per share which met the analyst consensus estimate. This i...

solid-biosciences-registers-q1-net-loss-of-243m-compared-with-301m-yoy-exits-quarter-with-cash--equivalents-worth-2061m
Solid Biosciences Registers Q1 Net Loss Of...
05/15/2024 11:59:41

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/10/2024 20:31:10

solid-biosciences-shares-are-trading-higher-after-the-company-received-rare-pediatric-disease-designation-for-sgt-003-from-the-fda
Solid Biosciences shares are trading highe...
04/02/2024 12:44:02

solid-biosciences-receives-rare-pediatric-disease-designation-from-the-fda-for-duchenne-muscular-dystrophy-gene-therapy-candidate-sgt-003
Solid Biosciences Receives Rare Pediatric ...
04/01/2024 11:48:23

Solid Biosciences Inc. (NASDAQ:SLDB), a life sciences company developing precision genetic medicines for neuromuscular and card...

william-blair-initiates-coverage-on-solid-biosciences-with-outperform-rating-announces-price-target-of-40
William Blair Initiates Coverage On Solid ...
03/28/2024 14:42:24

William Blair analyst Tim Lugo initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Outperform rating and announces ...

barclays-maintains-overweight-on-solid-biosciences-raises-price-target-to-21
Barclays Maintains Overweight on Solid Bio...
03/18/2024 10:25:01

Barclays analyst Gena Wang maintains Solid Biosciences (NASDAQ:SLDB) with a Overweight and raises the price target from $8 t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION